Details for New Drug Application (NDA): 021402
The generic ingredient in SYNTHROID is levothyroxine sodium. There is one drug master file entry for this compound. Fifty suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
Summary for 021402
| Tradename: | SYNTHROID |
| Applicant: | Abbvie |
| Ingredient: | levothyroxine sodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 021402
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SYNTHROID | levothyroxine sodium | TABLET;ORAL | 021402 | NDA | AbbVie Inc. | 0074-3727 | 0074-3727-19 | 1000 TABLET in 1 BOTTLE (0074-3727-19) |
| SYNTHROID | levothyroxine sodium | TABLET;ORAL | 021402 | NDA | AbbVie Inc. | 0074-3727 | 0074-3727-72 | 2 BLISTER PACK in 1 CARTON (0074-3727-72) / 7 TABLET in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ||||
| Approval Date: | Jul 24, 2002 | TE: | AB1,AB2 | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ||||
| Approval Date: | Jul 24, 2002 | TE: | AB1,AB2 | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ||||
| Approval Date: | Jul 24, 2002 | TE: | AB1,AB2 | RLD: | Yes | ||||
Complete Access Available with Subscription
